Roble, Belko & Company, Inc Abb Vie Inc. Transaction History
Roble, Belko & Company, Inc
- $634 Million
- Q3 2024
A detailed history of Roble, Belko & Company, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 4,456 shares of ABBV stock, worth $759,079. This represents 0.14% of its overall portfolio holdings.
Number of Shares
4,456
Previous 4,429
0.61%
Holding current value
$759,079
Previous $760,000
15.79%
% of portfolio
0.14%
Previous 0.13%
Shares
14 transactions
Others Institutions Holding ABBV
# of Institutions
3,817Shares Held
1.25BCall Options Held
13MPut Options Held
10M-
Vanguard Group Inc Valley Forge, PA172MShares$29.2 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.5 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$8.88 Billion0.84% of portfolio
-
Morgan Stanley New York, NY37.2MShares$6.34 Billion0.5% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $301B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...